Bio&Tech Smart Capital is the alliance of researchers and entrepreneurs with Venture Capital management professionals to transfer scientific knowledge to society, with the aim of transform projects into solid and profitable companies of spin off and startups emerging from universities, research laboratories, innovation and institutions.
that transform our lives
knowledge of investment sectors.
and knowledge in detail of what a project requires.
in strategy, management and access to international markets.
PROJECTION & ACCESS
to a network of partners in the Americas, Asia and Europe.
Four reasons to invest
in Bio&Tech Smart Capital:
√ Experienced entrepreneurs and investors with a track record of success.
√ Professionals connected to the Bio&Tech ecosystem and access to global transactions.
√ Investment in Projects with reduced risk.
√ Access to global multipliers.
Bio&Tech Smart Capital focuses its activity on:
● Digital technologies applied to life sciences (focus on automation and data science).
● Diagnostics and medical devices.
Selected based on a combination of: social impact, potential profitability and the team’s experience and knowledge of the sector.
Diversification: no sector will represent more than 50% of the invested capital.
Promoting open innovation
Exclusive dedication with innovation and their Business Development.
Competitiveness: Value Creation is the Shared by all and in increases.
IMPROVING THE ECOSYSTEM
Research results to innovate and generate value.
Tractor companies: the benefit of external talent .
SPEED AND VALUE
Stakeholders interact each other to develop businesses and create shared value.
Accesible innovation: SME`s can access latest advances innovation.
Investment funds are regulated by the National Securities Market Commission (CNMV).
NOSO CAPITAL SGEIC, S.A. Inscrita en Registro Oficial CNMV nº 149
Bio&Tech Smart Capital FCRE – Registro Oficial CNMV nº 64